Lifevantage (NASDAQ:LFVN) Share Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Lifevantage Corporation (NASDAQ:LFVN)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $5.72 and traded as high as $6.59. Lifevantage shares last traded at $6.37, with a volume of 75,057 shares trading hands.

Analysts Set New Price Targets

Several equities analysts have commented on the stock. Lake Street Capital lowered shares of Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 price target on the stock. in a research note on Thursday, May 7th. Weiss Ratings upgraded shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Hold rating, According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $5.00.

Lifevantage Price Performance

The company has a 50-day simple moving average of $6.95 and a 200-day simple moving average of $5.72. The stock has a market cap of $79.91 million, a PE ratio of 14.08 and a beta of 0.73.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). Lifevantage had a return on equity of 23.89% and a net margin of 2.94%.The company had revenue of $43.72 million for the quarter, compared to analysts’ expectations of $47.77 million. On average, equities analysts expect that Lifevantage Corporation will post 0.6 EPS for the current fiscal year.

Institutional Investors Weigh In On Lifevantage

Several institutional investors and hedge funds have recently made changes to their positions in the business. DGS Capital Management LLC purchased a new position in shares of Lifevantage during the 1st quarter worth approximately $44,000. Hsbc Holdings PLC acquired a new stake in shares of Lifevantage during the 1st quarter worth $51,000. JPMorgan Chase & Co. raised its position in shares of Lifevantage by 870.2% in the 2nd quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock worth $66,000 after buying an additional 4,499 shares during the period. Franklin Resources Inc. acquired a new position in Lifevantage in the fourth quarter valued at $74,000. Finally, Aristides Capital LLC purchased a new stake in Lifevantage during the fourth quarter valued at about $76,000. 35.32% of the stock is currently owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.